Aperio Group’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-10,899
Closed -$20K 2296
2018
Q4
$20K Buy
+10,899
New +$60.5K ﹤0.01% 2278
2018
Q2
Sell
-19,899
Closed -$139K 2274
2018
Q1
$139K Sell
19,899
-7,106
-26% -$82.7K ﹤0.01% 2187
2017
Q4
$341K Sell
27,005
-1,513
-5% -$18.5K ﹤0.01% 1883
2017
Q3
$339K Buy
28,518
+2,307
+9% +$34.2K ﹤0.01% 1854
2017
Q2
$392K Buy
26,211
+6,382
+32% +$85.1K ﹤0.01% 1763
2017
Q1
$189K Buy
19,829
+7,522
+61% +$63.5K ﹤0.01% 2051
2016
Q4
$109K Buy
+12,307
New +$111K ﹤0.01% 2079
2016
Q2
Sell
-18,120
Closed -$158K 2024
2016
Q1
$158K Buy
18,120
+6,093
+51% +$50.6K ﹤0.01% 1916
2015
Q4
$113K Buy
+12,027
New +$104K ﹤0.01% 1912

Other funds holding MDXG

Aperio Group's MDXG Position: Q1 2019 in Review

Aperio Group sold out of MiMedx Group (MDXG) in Q1 2019, closing a stake of 10,899 shares — an estimated $20K sold.

Aperio Group first reported a position in MDXG in Q4 2015 and held it in 9 quarters. The position peaked at $392K in Q2 2017. 18 funds tracked by Wall St. Rank hold MDXG as of Q1 2019.

  • Aperio Group reported no remaining MiMedx Group position as of Q1 2019 after selling out during the quarter.
  • Aperio Group sold 10,899 MiMedx Group shares in Q1 2019, an estimated $20K.
  • Aperio Group first reported a position in MiMedx Group in Q4 2015 and held it in 9 quarters.
  • Aperio Group's MiMedx Group position peaked at $392K in Q2 2017.
  • 18 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2019.

Based on Aperio Group's 13F filing for Q1 2019, filed 13 May 2019.